BTMD earnings date and last-quarter result: last quarter beat, P/E 4.72. Updated 2026-07-23.
biote (BTMD) Research Hub
biote (BTMD) trades on NASDAQ, US in the Healthcare (Medical - Care Facilities) sector. As of 2026-10-26, shares last closed at 1.15 USD (+7.48%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 4.72, market cap 0.11B. This hub links to the full technical, earnings and options research available for BTMD.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Care Facilities) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.15 USD (+7.48%) |
| 52-week range | 1 USD – 2.55 USD |
| Trend regime | Range |
| 14-day RSI | 50.9 (Neutral) |
| Trailing P/E | 4.72 |
| Market cap | 0.11B |
| Dividend yield | 0.00% |
Available research for BTMD
Covered Call on BTMD: how it works, illustrative setup around the real 1.15 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BTMD: how it works, illustrative setup around the real 1.15 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BTMD: how it works, illustrative setup around the real 1.15 USD price, max profit/loss, breakeven and when to use it. Educational.
BTMD technical analysis: range, last 1.15 USD, RSI 50.9, 52w range 1 USD–2.55 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BTMD in?
biote (BTMD) is classified under Healthcare (Medical - Care Facilities), listed on NASDAQ, US.
Is BTMD in an uptrend or downtrend?
As of 2026-10-26, BTMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BTMD's trailing P/E ratio?
BTMD's trailing P/E is 4.72, with a market cap of 0.11B. See the earnings research page for full valuation detail.